IMEPRINT-Incorporation of Microencapsulated Enzymes into screen PRINTed carbon graphite inks

IMEPRINT-将微囊化酶纳入丝网印刷碳石墨油墨

• 批准号: 131448
• 金额: $ 8.56万
• 依托单位: APPLIED ENZYME TECHNOLOGY LIMITED
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2014
• 资助国家: 英国
• 起止时间: 2014 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=131448
• 关键词: IMEPRINT; Incorporation; Microencapsulated; Enzymes; into

IMEPRINT-Incorporation of Microencapsulated Enzymes into screen PRINTed carbon graphite inks, aims to assess the feasibility of microencapsulating enzymes and mediators for inclusion in a water based carbon ink. If successful this system will be used to construct biosensors by screen printing. The microencapsulation of enzymes should lead to improved stability of enzymes during the printing process, enhanced enzyme stability and a reduction in the number of printing steps to construct the biosensor. The project thus covers the scope of three technology areas specified in the TSB Formulated Products call, namely formulation for delivery, formulation for stability and formulation for sustainability. This novel application of microencapsulation technology will deliver ingredients precisely to a very specific area on a biosensor. It will improve the stability of all the ingredients encapsulated and replace a solvent based screen printing ink with a water based environmentally friendly one. The use of this novel ink will lead to dramatic savings in labour costs, operating costs and raw material costs for the oroduction of diabetic test strips and other screen printed biosenors.

IMEPRINT-将微胶囊化酶并入丝网印刷的碳石墨油墨中，旨在评估微胶囊化酶和介质用于包含在水基碳油墨中的可行性。如果成功，该系统将用于通过丝网印刷构建生物传感器。酶的微胶囊化应导致在印刷过程中酶的稳定性提高，酶稳定性增强，并减少构建生物传感器的印刷步骤的数量。因此，该项目涵盖TSB配方产品呼吁中指定的三个技术领域，即交付配方，稳定性配方和可持续性配方。微胶囊技术的这种新应用将精确地将成分输送到生物传感器上的一个非常特定的区域。它将提高封装的所有成分的稳定性，并以水性环保油墨取代溶剂型丝网印刷油墨。这种新型油墨的使用将大大节省劳动力成本、运营成本和生产糖尿病试纸和其他丝网印刷生物传感器的原材料成本。